Logo image of ILM1.DE

MEDIOS AG (ILM1.DE) Stock Fundamental Analysis

FRA:ILM1 - Deutsche Boerse Ag - DE000A1MMCC8 - Common Stock - Currency: EUR

13.3  +0.14 (+1.06%)

Fundamental Rating

4

Overall ILM1 gets a fundamental rating of 4 out of 10. We evaluated ILM1 against 23 industry peers in the Health Care Providers & Services industry. While ILM1 seems to be doing ok healthwise, there are quite some concerns on its profitability. ILM1 has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year ILM1 was profitable.
ILM1 had a positive operating cash flow in the past year.
In the past 5 years ILM1 has always been profitable.
The reported operating cash flow has been mixed in the past 5 years: ILM1 reported negative operating cash flow in multiple years.
ILM1.DE Yearly Net Income VS EBIT VS OCF VS FCFILM1.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20M -20M 40M -40M 60M

1.2 Ratios

ILM1's Return On Assets of 1.41% is on the low side compared to the rest of the industry. ILM1 is outperformed by 65.38% of its industry peers.
ILM1 has a worse Return On Equity (2.54%) than 65.38% of its industry peers.
Looking at the Return On Invested Capital, with a value of 3.11%, ILM1 is in line with its industry, outperforming 42.31% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for ILM1 is in line with the industry average of 5.35%.
Industry RankSector Rank
ROA 1.41%
ROE 2.54%
ROIC 3.11%
ROA(3y)2.59%
ROA(5y)3.79%
ROE(3y)3.33%
ROE(5y)5.16%
ROIC(3y)3.35%
ROIC(5y)4.77%
ILM1.DE Yearly ROA, ROE, ROICILM1.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20 40

1.3 Margins

Looking at the Profit Margin, with a value of 0.70%, ILM1 is doing worse than 73.08% of the companies in the same industry.
In the last couple of years the Profit Margin of ILM1 has declined.
ILM1 has a Operating Margin of 1.52%. This is amonst the worse of the industry: ILM1 underperforms 80.77% of its industry peers.
In the last couple of years the Operating Margin of ILM1 has declined.
ILM1 has a Gross Margin of 7.19%. This is in the lower half of the industry: ILM1 underperforms 73.08% of its industry peers.
ILM1's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 1.52%
PM (TTM) 0.7%
GM 7.19%
OM growth 3Y4.86%
OM growth 5Y-4.9%
PM growth 3Y6.12%
PM growth 5Y-4.4%
GM growth 3Y0.78%
GM growth 5Y-2.74%
ILM1.DE Yearly Profit, Operating, Gross MarginsILM1.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 2 -2 4 6

More info and screens

4

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), ILM1 is destroying value.
ILM1 has about the same amout of shares outstanding than it did 1 year ago.
ILM1 has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, ILM1 has an improved debt to assets ratio.
ILM1.DE Yearly Shares OutstandingILM1.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M 20M
ILM1.DE Yearly Total Debt VS Total AssetsILM1.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M 400M 500M

2.2 Solvency

An Altman-Z score of 2.73 indicates that ILM1 is not a great score, but indicates only limited risk for bankruptcy at the moment.
The Altman-Z score of ILM1 (2.73) is better than 92.31% of its industry peers.
The Debt to FCF ratio of ILM1 is 8.07, which is on the high side as it means it would take ILM1, 8.07 years of fcf income to pay off all of its debts.
With a Debt to FCF ratio value of 8.07, ILM1 perfoms like the industry average, outperforming 50.00% of the companies in the same industry.
A Debt/Equity ratio of 0.06 indicates that ILM1 is not too dependend on debt financing.
ILM1's Debt to Equity ratio of 0.06 is amongst the best of the industry. ILM1 outperforms 100.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.06
Debt/FCF 8.07
Altman-Z 2.73
ROIC/WACC0.44
WACC7.15%
ILM1.DE Yearly LT Debt VS Equity VS FCFILM1.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 100M 200M 300M 400M

2.3 Liquidity

ILM1 has a Current Ratio of 0.99. This is a bad value and indicates that ILM1 is not financially healthy enough and could expect problems in meeting its short term obligations.
With a decent Current ratio value of 0.99, ILM1 is doing good in the industry, outperforming 65.38% of the companies in the same industry.
A Quick Ratio of 0.76 indicates that ILM1 may have some problems paying its short term obligations.
The Quick ratio of ILM1 (0.76) is better than 61.54% of its industry peers.
Industry RankSector Rank
Current Ratio 0.99
Quick Ratio 0.76
ILM1.DE Yearly Current Assets VS Current LiabilitesILM1.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M

More info and screens

6

3. Growth

3.1 Past

ILM1 shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -32.83%.
The Earnings Per Share has been growing by 20.26% on average over the past years. This is a very strong growth
The Revenue has been growing slightly by 5.68% in the past year.
ILM1 shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 40.34% yearly.
EPS 1Y (TTM)-32.83%
EPS 3Y31.79%
EPS 5Y20.26%
EPS Q2Q%-45.7%
Revenue 1Y (TTM)5.68%
Revenue growth 3Y41.76%
Revenue growth 5Y40.34%
Sales Q2Q%0.67%

3.2 Future

ILM1 is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 21.66% yearly.
Based on estimates for the next years, ILM1 will show a small growth in Revenue. The Revenue will grow by 4.43% on average per year.
EPS Next Y3.88%
EPS Next 2Y22.29%
EPS Next 3Y21.21%
EPS Next 5Y21.66%
Revenue Next Year4.86%
Revenue Next 2Y6.6%
Revenue Next 3Y6.16%
Revenue Next 5Y4.43%

3.3 Evolution

The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
ILM1.DE Yearly Revenue VS EstimatesILM1.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 500M 1B 1.5B 2B 2.5B
ILM1.DE Yearly EPS VS EstimatesILM1.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 0.5 1 1.5 2

More info and screens

5

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 25.09 indicates a quite expensive valuation of ILM1.
61.54% of the companies in the same industry are cheaper than ILM1, based on the Price/Earnings ratio.
The average S&P500 Price/Earnings ratio is at 29.35. ILM1 is around the same levels.
The Price/Forward Earnings ratio is 9.04, which indicates a very decent valuation of ILM1.
Compared to the rest of the industry, the Price/Forward Earnings ratio of ILM1 indicates a rather cheap valuation: ILM1 is cheaper than 96.15% of the companies listed in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.10, ILM1 is valued rather cheaply.
Industry RankSector Rank
PE 25.09
Fwd PE 9.04
ILM1.DE Price Earnings VS Forward Price EarningsILM1.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, ILM1 is valued a bit cheaper than the industry average as 61.54% of the companies are valued more expensively.
ILM1's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. ILM1 is cheaper than 61.54% of the companies in the same industry.
Industry RankSector Rank
P/FCF 11.61
EV/EBITDA 9.23
ILM1.DE Per share dataILM1.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
ILM1's earnings are expected to grow with 21.21% in the coming years. This may justify a more expensive valuation.
PEG (NY)6.46
PEG (5Y)1.24
EPS Next 2Y22.29%
EPS Next 3Y21.21%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for ILM1!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

MEDIOS AG

FRA:ILM1 (3/7/2025, 7:00:00 PM)

13.3

+0.14 (+1.06%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)11-12 2024-11-12
Earnings (Next)03-26 2025-03-26/amc
Inst Owners39.37%
Inst Owner ChangeN/A
Ins Owners19.96%
Ins Owner ChangeN/A
Market Cap339.28M
Analysts87.14
Price Target29.16 (119.25%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-6.54%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-1.41%
EPS NY rev (3m)-15.01%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.37%
Revenue NY rev (3m)-5%
Valuation
Industry RankSector Rank
PE 25.09
Fwd PE 9.04
P/S 0.18
P/FCF 11.61
P/OCF 10.23
P/B 0.67
P/tB N/A
EV/EBITDA 9.23
EPS(TTM)0.53
EY3.98%
EPS(NY)1.47
Fwd EY11.06%
FCF(TTM)1.15
FCFY8.61%
OCF(TTM)1.3
OCFY9.78%
SpS72.2
BVpS19.89
TBVpS-0.24
PEG (NY)6.46
PEG (5Y)1.24
Profitability
Industry RankSector Rank
ROA 1.41%
ROE 2.54%
ROCE 4.79%
ROIC 3.11%
ROICexc 3.52%
ROICexgc 751.1%
OM 1.52%
PM (TTM) 0.7%
GM 7.19%
FCFM 1.59%
ROA(3y)2.59%
ROA(5y)3.79%
ROE(3y)3.33%
ROE(5y)5.16%
ROIC(3y)3.35%
ROIC(5y)4.77%
ROICexc(3y)4.3%
ROICexc(5y)5.87%
ROICexgc(3y)13.91%
ROICexgc(5y)13.77%
ROCE(3y)5.18%
ROCE(5y)7.35%
ROICexcg growth 3Y32.72%
ROICexcg growth 5Y-2.81%
ROICexc growth 3Y2.41%
ROICexc growth 5Y-9.57%
OM growth 3Y4.86%
OM growth 5Y-4.9%
PM growth 3Y6.12%
PM growth 5Y-4.4%
GM growth 3Y0.78%
GM growth 5Y-2.74%
F-Score4
Asset Turnover2.02
Health
Industry RankSector Rank
Debt/Equity 0.06
Debt/FCF 8.07
Debt/EBITDA 0.54
Cap/Depr 14.66%
Cap/Sales 0.21%
Interest Coverage 5.03
Cash Conversion 60.33%
Profit Quality 226.94%
Current Ratio 0.99
Quick Ratio 0.76
Altman-Z 2.73
F-Score4
WACC7.15%
ROIC/WACC0.44
Cap/Depr(3y)31.65%
Cap/Depr(5y)67.46%
Cap/Sales(3y)0.44%
Cap/Sales(5y)0.5%
Profit Quality(3y)304.44%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-32.83%
EPS 3Y31.79%
EPS 5Y20.26%
EPS Q2Q%-45.7%
EPS Next Y3.88%
EPS Next 2Y22.29%
EPS Next 3Y21.21%
EPS Next 5Y21.66%
Revenue 1Y (TTM)5.68%
Revenue growth 3Y41.76%
Revenue growth 5Y40.34%
Sales Q2Q%0.67%
Revenue Next Year4.86%
Revenue Next 2Y6.6%
Revenue Next 3Y6.16%
Revenue Next 5Y4.43%
EBIT growth 1Y-5.8%
EBIT growth 3Y48.65%
EBIT growth 5Y33.47%
EBIT Next Year124.28%
EBIT Next 3Y45.56%
EBIT Next 5Y33.52%
FCF growth 1Y-7.5%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-15.01%
OCF growth 3YN/A
OCF growth 5YN/A